Tags: Drug.

Tasquinimod (ABR-215050 CID 54682876) is a novel oral drug currently being investigated for the treatment of solid tumors. Tasquinimod has been mostly studied in prostate cancer but its mechanism of action suggests that it could be used to treat other cancers. Castration-resistant prostate cancer (CRPC) formerly called hormone-resistant or hormone-refractory prostate cancer is prostate cancer that grows despite medical or surgical androgen deprivation therapy.

Chemical_structure_of_tasquinimod.svg
CAS number
254964-60-8
FDA UNII code
756U07KN1R
IUPAC name
4-hydroxy-5-methoxy-N1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-12-dihydroquinoline-3-carboxamide
PubChem
54682876

Loading...

This page contains content from the copyrighted Wikipedia article "Tasquinimod"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.